<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04680793</url>
  </required_header>
  <id_info>
    <org_study_id>2019-A02154-53</org_study_id>
    <nct_id>NCT04680793</nct_id>
  </id_info>
  <brief_title>Effects of a Multidisciplinary Outpatient Rehabilitation Program in Patients With Ehlers-Danlos Syndrome.</brief_title>
  <official_title>Effects of a Multidisciplinary Outpatient Rehabilitation Program on Physical Capacity and Quality of Life in Patients With Ehlers-Danlos Syndrome.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hakimi Adrien</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Clinique de la Mitterie</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The management of patients with Ehlers-Danlos syndrome (EDS) is still underdeveloped in&#xD;
      healthcare institutions in France. Although multidisciplinary management through exercise&#xD;
      rehabilitation has demonstrated its benefits in many chronic pathologies, it has not been&#xD;
      evaluated for EDS. As a result, to date there is no evidence of its effectiveness in patients&#xD;
      with EDS. The objective of this study is therefore to objectively evaluate the effectiveness&#xD;
      of such a treatment on the different dimensions of these patients' health.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Actual">September 22, 2020</start_date>
  <completion_date type="Anticipated">November 2022</completion_date>
  <primary_completion_date type="Anticipated">November 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>Patients are assessed 9 weeks before the start of the program, at the beginning and at the end of the program, and 6 weeks and 6 months after the end of the program. The 9-week period before the program is used as a control condition. It is of the same duration as the program, which also lasts 9 weeks. Patients are asked not to change their lifestyle during the 9-week period before the rehabilitation program.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Distance covered in the 6-minute walk test</measure>
    <time_frame>9 weeks before baseline ; Baseline ; 9 weeks ; 15 weeks ; 8 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Other data from the 6-minute walk test</measure>
    <time_frame>9 weeks before baseline ; Baseline ; 9 weeks ; 15 weeks ; 8 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time of an endurance test on a cyclo-ergometer</measure>
    <time_frame>Baseline ; 9 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Area swept by the gravity center during a balance test on a posturological platform</measure>
    <time_frame>9 weeks before baseline ; Baseline ; 9 weeks ; 15 weeks ; 8 months</time_frame>
    <description>Four balance tests : bipodal with eyes open, bipodal with eyes closed and unipodal with eyes open on the two sides</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Tampa scale for kinesiophobia (questionnaire)</measure>
    <time_frame>9 weeks before baseline ; Baseline ; 9 weeks ; 15 weeks ; 8 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Brief pain inventory (questionnaire)</measure>
    <time_frame>9 weeks before baseline ; Baseline ; 9 weeks ; 15 weeks ; 8 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Nijmegen questionnaire</measure>
    <time_frame>9 weeks before baseline ; Baseline ; 9 weeks ; 15 weeks ; 8 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Multidimensional fatigue inventory (questionnaire)</measure>
    <time_frame>9 weeks before baseline ; Baseline ; 9 weeks ; 15 weeks ; 8 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Medical outcome study short form 36 (questionnaire)</measure>
    <time_frame>9 weeks before baseline ; Baseline ; 9 weeks ; 15 weeks ; 8 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospital anxiety and depression scale (questionnaire)</measure>
    <time_frame>9 weeks before baseline ; Baseline ; 9 weeks ; 15 weeks ; 8 months</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">24</enrollment>
  <condition>Ehlers-Danlos Syndrome</condition>
  <arm_group>
    <arm_group_label>EDS Patients</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>No intervention during the control period (9 weeks) and then experimental during the rehabilitation stage (9 weeks).</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Rehabilitation</intervention_name>
    <description>The program takes place over a total period of 9 weeks: for 4 weeks they will be cared for two days a week, then after a week's break, for 4 weeks they will be cared for three days a week for a total of approximately 80 hours of care. The program is multidisciplinary and includes: balneotherapy, ergometry, occupational therapy, gymnastics, physiotherapy, walking, sophrology, yoga as well as different workshops for the therapeutic education of the patient led by several professionals (dieticians, physiotherapists, doctors, psychologists).</description>
    <arm_group_label>EDS Patients</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  EDS diagnosis.&#xD;
&#xD;
          -  Inclusion in the rehabilitation program.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Absolute and relative cardio-vascular contraindications to rehabilitation.&#xD;
&#xD;
          -  Other contraindications to exercise.&#xD;
&#xD;
          -  Psychological contraindication (Beck questionnaire score â‰¥ 20)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Patrick MUCCI, Prof.</last_name>
    <role>Study Director</role>
    <affiliation>URePSSS</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Cyrille BERGOIN, Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Clinique de la Mitterie</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Clinique de la Mitterie</name>
      <address>
        <city>Lomme</city>
        <zip>59160</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>December 2020</verification_date>
  <study_first_submitted>December 16, 2020</study_first_submitted>
  <study_first_submitted_qc>December 18, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 23, 2020</study_first_posted>
  <last_update_submitted>December 18, 2020</last_update_submitted>
  <last_update_submitted_qc>December 18, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">December 23, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Clinique de la Mitterie</investigator_affiliation>
    <investigator_full_name>Hakimi Adrien</investigator_full_name>
    <investigator_title>PhD Student</investigator_title>
  </responsible_party>
  <keyword>Rehabilitation; Ehlers-Danlos syndrome; Quality of life; Physical capacity</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ehlers-Danlos Syndrome</mesh_term>
    <mesh_term>Syndrome</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

